-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

--Morgan Stanley Adjusts TransMedics Group Price Target to $63 From $54, Maintains Equal Weight Rating

--Morgan Stanley Adjusts TransMedics Group Price Target to $63 From $54, Maintains Equal Weight Rating

MT Newswires · 01/06/2023 06:24